NCT06211244View on ClinicalTrials.gov

Association of Serum Eotaxin Levels and Markers of Myocardiac Injury in Hemodialysis Patients

CompletedOBSERVATIONAL
Enrollment

291

Participants

Timeline

Start Date

May 2, 2024

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2024

Conditions
Myocardium; InjuryCoronary Artery Disease
Trial Locations (1)

Unknown

Tungs' Taichung MetroHarbour Hospital, Taichung

All Listed Sponsors
lead

Tungs' Taichung Metroharbour Hospital

OTHER

NCT06211244 - Association of Serum Eotaxin Levels and Markers of Myocardiac Injury in Hemodialysis Patients | Biotech Hunter | Biotech Hunter